Predictive Oncology Subsidiary Helomics Executes Next Phase of Agreement with Interpace to Enhance the Diagnosis of Thyroid Cancer via AI-Driven Models

July 30, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search